Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
Valeria Ceolin, Erica Brivio, Harm van Tinteren, Susan R. Rheingold, Allison Barz Leahy, Britta Vormoor, Maureen M. O’Brien, Jeremy D. Rubinstein, Krzysztof Kałwak, Barbara De Moerloose, Elad Jacoby, Peter Bader, Monica López‐Duarte, Bianca F. Goemans, Franco Locatelli, Peter M. Hoogerbrugge, Friso Calkoen, C. Michel Zwaan
Topics & Concepts
MedicineMinimal residual diseaseCalicheamicinRefractory (planetary science)Internal medicineGastroenterologyCartChimeric antigen receptorCumulative incidenceLeukemiaImmunologySurgeryImmunotherapyAntibodyCancerTransplantationAstrobiologyEngineeringMechanical engineeringPhysicsCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchVirus-based gene therapy research